Skip Main Navigation
Page Content
This event has ended

Commercialisation of your regenerative medicine research: lessons from spin-out successes.

Oxbridge Biotech Roundtable

Wednesday, February 6, 2013 from 6:00 PM to 9:00 PM (GMT)

Commercialisation of your regenerative medicine...

Ticket Information

Type End Quantity
students/postdocs/faculty/staff Ended Free  
Industry professionals Ended Free  

Who's Going

Loading your connections...

Share Commercialisation of your regenerative medicine research: lessons from spin-out successes.

Event Details

Commercialisation of your regenerative medicine research: lessons from spin-out successes with..

John Sinden, CSO ReNeuron,

Karen Hodgkin, Head of clinical development, Cell Medica

Paul Kemp, CSO and CEO of Intercytex. 

Hear from our distingushed speakers who have 'been there' and 'done it'.

Discussion starts at 6pm and will be followed by a drinks reception and networking. 

Sponsored by OBN.



Regenerative medicine is a multidiscipline that brings together tissue engineering, gene therapy, cellular therapeutics and transplantation. Fields that were considered separate are now combined to make new type of treatments a possibility. Despite the economic potential of regenerative medicine, several challenges are delaying the development of cell therapy-based products. The regulatory environment and the market that cell therapies and regenerative medicine have to face are fundamentally different from the traditional drug market. Also, the manufacturing of a living ‘product’ makes the logistics, the types of infrastructure, the storage and the delivery requirements more complex. This requires the establishment of new technologies and techniques to provide standardisation, effectiveness and safety of the product.
The company needs to decide whether to commercialise a product (i.e. sourcing cells from a donor that can be applied universally) or a service (i.e. providing patients with their own stem cells). This choice drastically changes the business model the companies have to adapt. Notably, further organisation is required in the latter example as providing a service of this kind necessitates coordination with hospitals and healthcare professionals. 

A final obstacle for translation into the clinic of regenerative medicine products is the ‘valley of death’, defined as the lack of funding between early pre-clinical to successfully completion of Phase II clinical trials. The fact that regenerative medicine is seen as an expensive and risky process with long term timescale makes the investments from the private sector even more difficult to get.


Despite those challenges, there have already been a number of commercialised products that have reached the market and the field of regenerative medicine is attracting increasing commercial interest.

How are companies and institution bringing regenerative medicine to life?


Have questions about Commercialisation of your regenerative medicine research: lessons from spin-out successes.? Contact Oxbridge Biotech Roundtable

When & Where

Main Seminar Room
South Parks Road
OX1 3QU Oxford
United Kingdom

Wednesday, February 6, 2013 from 6:00 PM to 9:00 PM (GMT)

  Add to my calendar


Oxbridge Biotech Roundtable



Oxbridge Biotechnology Roundtable is an inter-campus movement to foster the next wave of Innovation by connecting industry professionals to academicinnovators from business, law, science (and others disciplines) across Oxbridge, London, reast of the UK and beyond.

We seek to establish an inter-campus conversation about biotech, pharma and the life sciences industry and other disciplines in longer term. Our aim uis to pair young upcoming innovators to established professionals, in our quest to MOVE IDEAS FORWARD.

Since starting in Summer of 2011 we've grown to over 4,000 members across Cambridge, Oxford, London and San Diego.  We engage our community via: Education, Consulting, Communication (Blog) and a platform to source bright new ideas to market.



  Contact the Organizer

Interested in hosting your own event?

Join millions of people on Eventbrite.

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.